(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(-0.34%) $81.46
(-3.13%) $2.60
(0.01%) $2 336.90
(0.61%) $29.44
(0.28%) $1 009.00
(-0.06%) $0.933
(0.45%) $10.68
(-0.05%) $0.791
(0.86%) $85.73
-2.78% $ 0.350
Live Chart Being Loaded With Signals
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage...
Stats | |
---|---|
Tagesvolumen | 2.62M |
Durchschnittsvolumen | 1.36M |
Marktkapitalisierung | 422.13M |
EPS | $-0.250 ( Q2 | 2023-12-31 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-08-28 |
Last Dividend | $0.111 ( 2004-10-11 ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.830 (Sector) 0 (Industry) 0 |
ATR14 | $0.00200 (0.56%) |
Volumen Korrelation
Opthea Ltd Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Opthea Ltd Korrelation - Währung/Rohstoff
Opthea Ltd Finanzdaten
Annual | 2023 |
Umsatz: | $161 163 |
Bruttogewinn: | $-89 309.00 (-55.42 %) |
EPS: | $-0.450 |
FY | 2023 |
Umsatz: | $161 163 |
Bruttogewinn: | $-89 309.00 (-55.42 %) |
EPS: | $-0.450 |
FY | 2022 |
Umsatz: | $125 047 |
Bruttogewinn: | $-107 422 (-85.91 %) |
EPS: | $-0.340 |
FY | 2021 |
Umsatz: | $68 613.00 |
Bruttogewinn: | $0.00 (0.00 %) |
EPS: | $-0.195 |
Financial Reports:
No articles found.
Opthea Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.111 | 2004-10-11 |
Last Dividend | $0.111 | 2004-10-11 |
Next Dividend | $0 | N/A |
Payout Date | 2004-11-01 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.111 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.01 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2004 | $0.111 | 5.43% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
11 Oct 2004 | $0.111 | 25 Aug 2004 | 15 Oct 2004 | 01 Nov 2004 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
EZL.AX | Dividend Royal | 2024-02-02 | Semi-Annually | 24 | 11.64% | 8.24 |
GRR.AX | Dividend Royal | 2024-03-12 | Semi-Annually | 14 | 11.88% | 7.99 |
RKN.AX | Dividend Royal | 2023-08-31 | Annually | 22 | 15.73% | 7.24 |
TWR.AX | Dividend King | 2024-06-12 | Annually | 25 | 5.98% | 7.21 |
YAL.AX | Dividend Royal | 2024-03-12 | Annually | 7 | 12.76% | 7.18 |
SHM.AX | Dividend Royal | 2024-03-14 | Semi-Annually | 9 | 14.97% | 7.14 |
HZN.AX | Dividend Royal | 2024-04-18 | Semi-Annually | 4 | 18.99% | 7.06 |
BHP.AX | Dividend Royal | 2024-03-07 | Semi-Annually | 37 | 6.46% | 6.97 |
CDD.AX | Ex Dividend King | 2024-05-24 | Annually | 21 | 91.43% | 6.79 |
KSL.AX | Dividend Royal | 2024-03-05 | Semi-Annually | 9 | 9.58% | 6.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -1 383.77 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -1.467 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | 8.77 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 5.10 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 5.00 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 4.82 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.000780 | -1.500 | 9.99 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -8.08 | 1.000 | -4.10 | -4.10 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.306 | 2.00 | -0.102 | -0.204 | [0 - 30] |
freeCashFlowPerShareTTM | -0.306 | 2.00 | -0.153 | -0.306 | [0 - 20] |
debtEquityRatioTTM | -0.00277 | -1.500 | -0.0111 | 0.0166 | [0 - 2.5] |
grossProfitMarginTTM | -0.169 | 1.000 | -6.15 | -6.15 | [0.2 - 0.8] |
operatingProfitMarginTTM | -1 413.43 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -1 397.12 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.00106 | 0.800 | -3.33 | -2.66 | [0.5 - 2] |
Total Score | -0.994 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.579 | 1.000 | -0.159 | 0 | [1 - 100] |
returnOnEquityTTM | 8.77 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.306 | 2.00 | -0.102 | -0.306 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.306 | 2.00 | -0.102 | -0.204 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0607 | 1.500 | -3.74 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -1 027.63 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -0.617 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Opthea Ltd
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema (DME), as well as a first in class VEGF-C/D inhibitors for treatment with VEGF-A inhibitors to treat wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.